カテゴリ： Market Monitor Global, 世界, 医療/バイオ

出血性敗血症ワクチンのグローバル市場展望 2023年-2029年：オイルアジュバントワクチン、水酸化アルミニウムアジュバントワクチン

■ 英語タイトル：Hemorrhagic Septicemia Vaccines Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5610）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5610
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆医療
■ ページ数：116
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[出血性敗血症ワクチンのグローバル市場展望 2023年-2029年：オイルアジュバントワクチン、水酸化アルミニウムアジュバントワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の出血性敗血症ワクチン市場規模と予測を収録しています。・世界の出血性敗血症ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の出血性敗血症ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の出血性敗血症ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「オイルアジュバントワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

出血性敗血症ワクチンのグローバル主要企業は、Bio-Labs (PVT) Limited、 Brilliant Bio Pharma、 C.A. Laboratorios Asociados (CALA)、 Ceva Santé Animale、 Vecol、 FATRO、 Indian Immunologicals Limited、 Institute of Animal Health and Veterinary Biologicals、 Institute of Veterinary Preventive Medicine、 Intervac (PVT) Ltd、 LABIOFAM、 Laboratorios Laverlam、 Laboratorios Ovejero、 Limor de Colombia、 National Veterinary Research Institute、 Zoetisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、出血性敗血症ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の出血性敗血症ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の出血性敗血症ワクチン市場：タイプ別市場シェア、2022年
・オイルアジュバントワクチン、水酸化アルミニウムアジュバントワクチン

世界の出血性敗血症ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の出血性敗血症ワクチン市場：用途別市場シェア、2022年
・牛、水牛

世界の出血性敗血症ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の出血性敗血症ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における出血性敗血症ワクチンのグローバル売上、2018年-2023年
・主要企業における出血性敗血症ワクチンのグローバル売上シェア、2022年
・主要企業における出血性敗血症ワクチンのグローバル販売量、2018年-2023年
・主要企業における出血性敗血症ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bio-Labs (PVT) Limited、 Brilliant Bio Pharma、 C.A. Laboratorios Asociados (CALA)、 Ceva Santé Animale、 Vecol、 FATRO、 Indian Immunologicals Limited、 Institute of Animal Health and Veterinary Biologicals、 Institute of Veterinary Preventive Medicine、 Intervac (PVT) Ltd、 LABIOFAM、 Laboratorios Laverlam、 Laboratorios Ovejero、 Limor de Colombia、 National Veterinary Research Institute、 Zoetis

*************************************************************

・調査・分析レポートの概要
出血性敗血症ワクチン市場の定義
市場セグメント
世界の出血性敗血症ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の出血性敗血症ワクチン市場規模
世界の出血性敗血症ワクチン市場規模：2022年 VS 2029年
世界の出血性敗血症ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの出血性敗血症ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の出血性敗血症ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：オイルアジュバントワクチン、水酸化アルミニウムアジュバントワクチン
出血性敗血症ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：牛、水牛
出血性敗血症ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別出血性敗血症ワクチン市場規模 2022年と2029年
地域別出血性敗血症ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Bio-Labs (PVT) Limited、 Brilliant Bio Pharma、 C.A. Laboratorios Asociados (CALA)、 Ceva Santé Animale、 Vecol、 FATRO、 Indian Immunologicals Limited、 Institute of Animal Health and Veterinary Biologicals、 Institute of Veterinary Preventive Medicine、 Intervac (PVT) Ltd、 LABIOFAM、 Laboratorios Laverlam、 Laboratorios Ovejero、 Limor de Colombia、 National Veterinary Research Institute、 Zoetis
...

Haemorrhagic septicaemia (HS), an economically important disease of cattle and buffaloes, is caused by Pasteurella multocida (6:B).
This report aims to provide a comprehensive presentation of the global market for Hemorrhagic Septicemia Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemorrhagic Septicemia Vaccines. This report contains market size and forecasts of Hemorrhagic Septicemia Vaccines in global, including the following market information:
Global Hemorrhagic Septicemia Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hemorrhagic Septicemia Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hemorrhagic Septicemia Vaccines companies in 2022 (%)
The global Hemorrhagic Septicemia Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oil–adjuvant Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hemorrhagic Septicemia Vaccines include Bio-Labs (PVT) Limited, Brilliant Bio Pharma, C.A. Laboratorios Asociados (CALA), Ceva Santé Animale, Vecol, FATRO, Indian Immunologicals Limited, Institute of Animal Health and Veterinary Biologicals and Institute of Veterinary Preventive Medicine, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemorrhagic Septicemia Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemorrhagic Septicemia Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hemorrhagic Septicemia Vaccines Market Segment Percentages, by Type, 2022 (%)
Oil–adjuvant Vaccines
Aluminum hydroxide-adjuvant Vaccines
Global Hemorrhagic Septicemia Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hemorrhagic Septicemia Vaccines Market Segment Percentages, by Application, 2022 (%)
Cattle
Buffaloes
Global Hemorrhagic Septicemia Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hemorrhagic Septicemia Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemorrhagic Septicemia Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hemorrhagic Septicemia Vaccines revenues share in global market, 2022 (%)
Key companies Hemorrhagic Septicemia Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hemorrhagic Septicemia Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Labs (PVT) Limited
Brilliant Bio Pharma
C.A. Laboratorios Asociados (CALA)
Ceva Santé Animale
Vecol
FATRO
Indian Immunologicals Limited
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
Intervac (PVT) Ltd
LABIOFAM
Laboratorios Laverlam
Laboratorios Ovejero
Limor de Colombia
National Veterinary Research Institute
Zoetis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemorrhagic Septicemia Vaccines, market overview.
Chapter 2: Global Hemorrhagic Septicemia Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Hemorrhagic Septicemia Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemorrhagic Septicemia Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hemorrhagic Septicemia Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Hemorrhagic Septicemia Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemorrhagic Septicemia Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemorrhagic Septicemia Vaccines Overall Market Size
2.1 Global Hemorrhagic Septicemia Vaccines Market Size: 2022 VS 2029
2.2 Global Hemorrhagic Septicemia Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hemorrhagic Septicemia Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Hemorrhagic Septicemia Vaccines Players in Global Market
3.2 Top Global Hemorrhagic Septicemia Vaccines Companies Ranked by Revenue
3.3 Global Hemorrhagic Septicemia Vaccines Revenue by Companies
3.4 Global Hemorrhagic Septicemia Vaccines Sales by Companies
3.5 Global Hemorrhagic Septicemia Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hemorrhagic Septicemia Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hemorrhagic Septicemia Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hemorrhagic Septicemia Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Hemorrhagic Septicemia Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Hemorrhagic Septicemia Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hemorrhagic Septicemia Vaccines Market Size Markets, 2022 & 2029
4.1.2 Oil–adjuvant Vaccines
4.1.3 Aluminum hydroxide-adjuvant Vaccines
4.2 By Type – Global Hemorrhagic Septicemia Vaccines Revenue & Forecasts
4.2.1 By Type – Global Hemorrhagic Septicemia Vaccines Revenue, 2018-2023
4.2.2 By Type – Global Hemorrhagic Septicemia Vaccines Revenue, 2024-2029
4.2.3 By Type – Global Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
4.3 By Type – Global Hemorrhagic Septicemia Vaccines Sales & Forecasts
4.3.1 By Type – Global Hemorrhagic Septicemia Vaccines Sales, 2018-2023
4.3.2 By Type – Global Hemorrhagic Septicemia Vaccines Sales, 2024-2029
4.3.3 By Type – Global Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
4.4 By Type – Global Hemorrhagic Septicemia Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hemorrhagic Septicemia Vaccines Market Size, 2022 & 2029
5.1.2 Cattle
5.1.3 Buffaloes
5.2 By Application – Global Hemorrhagic Septicemia Vaccines Revenue & Forecasts
5.2.1 By Application – Global Hemorrhagic Septicemia Vaccines Revenue, 2018-2023
5.2.2 By Application – Global Hemorrhagic Septicemia Vaccines Revenue, 2024-2029
5.2.3 By Application – Global Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
5.3 By Application – Global Hemorrhagic Septicemia Vaccines Sales & Forecasts
5.3.1 By Application – Global Hemorrhagic Septicemia Vaccines Sales, 2018-2023
5.3.2 By Application – Global Hemorrhagic Septicemia Vaccines Sales, 2024-2029
5.3.3 By Application – Global Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
5.4 By Application – Global Hemorrhagic Septicemia Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hemorrhagic Septicemia Vaccines Market Size, 2022 & 2029
6.2 By Region – Global Hemorrhagic Septicemia Vaccines Revenue & Forecasts
6.2.1 By Region – Global Hemorrhagic Septicemia Vaccines Revenue, 2018-2023
6.2.2 By Region – Global Hemorrhagic Septicemia Vaccines Revenue, 2024-2029
6.2.3 By Region – Global Hemorrhagic Septicemia Vaccines Revenue Market Share, 2018-2029
6.3 By Region – Global Hemorrhagic Septicemia Vaccines Sales & Forecasts
6.3.1 By Region – Global Hemorrhagic Septicemia Vaccines Sales, 2018-2023
6.3.2 By Region – Global Hemorrhagic Septicemia Vaccines Sales, 2024-2029
6.3.3 By Region – Global Hemorrhagic Septicemia Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hemorrhagic Septicemia Vaccines Revenue, 2018-2029
6.4.2 By Country – North America Hemorrhagic Septicemia Vaccines Sales, 2018-2029
6.4.3 US Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.4.4 Canada Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.4.5 Mexico Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hemorrhagic Septicemia Vaccines Revenue, 2018-2029
6.5.2 By Country – Europe Hemorrhagic Septicemia Vaccines Sales, 2018-2029
6.5.3 Germany Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.4 France Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.5 U.K. Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.6 Italy Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.7 Russia Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.5.9 Benelux Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hemorrhagic Septicemia Vaccines Revenue, 2018-2029
6.6.2 By Region – Asia Hemorrhagic Septicemia Vaccines Sales, 2018-2029
6.6.3 China Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.6.4 Japan Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.6.5 South Korea Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.6.7 India Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hemorrhagic Septicemia Vaccines Revenue, 2018-2029
6.7.2 By Country – South America Hemorrhagic Septicemia Vaccines Sales, 2018-2029
6.7.3 Brazil Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.7.4 Argentina Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hemorrhagic Septicemia Vaccines Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hemorrhagic Septicemia Vaccines Sales, 2018-2029
6.8.3 Turkey Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.8.4 Israel Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
6.8.6 UAE Hemorrhagic Septicemia Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bio-Labs (PVT) Limited
7.1.1 Bio-Labs (PVT) Limited Company Summary
7.1.2 Bio-Labs (PVT) Limited Business Overview
7.1.3 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Major Product Offerings
7.1.4 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Bio-Labs (PVT) Limited Key News & Latest Developments
7.2 Brilliant Bio Pharma
7.2.1 Brilliant Bio Pharma Company Summary
7.2.2 Brilliant Bio Pharma Business Overview
7.2.3 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Major Product Offerings
7.2.4 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Brilliant Bio Pharma Key News & Latest Developments
7.3 C.A. Laboratorios Asociados (CALA)
7.3.1 C.A. Laboratorios Asociados (CALA) Company Summary
7.3.2 C.A. Laboratorios Asociados (CALA) Business Overview
7.3.3 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Major Product Offerings
7.3.4 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 C.A. Laboratorios Asociados (CALA) Key News & Latest Developments
7.4 Ceva Santé Animale
7.4.1 Ceva Santé Animale Company Summary
7.4.2 Ceva Santé Animale Business Overview
7.4.3 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Major Product Offerings
7.4.4 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Ceva Santé Animale Key News & Latest Developments
7.5 Vecol
7.5.1 Vecol Company Summary
7.5.2 Vecol Business Overview
7.5.3 Vecol Hemorrhagic Septicemia Vaccines Major Product Offerings
7.5.4 Vecol Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Vecol Key News & Latest Developments
7.6 FATRO
7.6.1 FATRO Company Summary
7.6.2 FATRO Business Overview
7.6.3 FATRO Hemorrhagic Septicemia Vaccines Major Product Offerings
7.6.4 FATRO Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 FATRO Key News & Latest Developments
7.7 Indian Immunologicals Limited
7.7.1 Indian Immunologicals Limited Company Summary
7.7.2 Indian Immunologicals Limited Business Overview
7.7.3 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Major Product Offerings
7.7.4 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Indian Immunologicals Limited Key News & Latest Developments
7.8 Institute of Animal Health and Veterinary Biologicals
7.8.1 Institute of Animal Health and Veterinary Biologicals Company Summary
7.8.2 Institute of Animal Health and Veterinary Biologicals Business Overview
7.8.3 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Major Product Offerings
7.8.4 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Institute of Animal Health and Veterinary Biologicals Key News & Latest Developments
7.9 Institute of Veterinary Preventive Medicine
7.9.1 Institute of Veterinary Preventive Medicine Company Summary
7.9.2 Institute of Veterinary Preventive Medicine Business Overview
7.9.3 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Major Product Offerings
7.9.4 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Institute of Veterinary Preventive Medicine Key News & Latest Developments
7.10 Intervac (PVT) Ltd
7.10.1 Intervac (PVT) Ltd Company Summary
7.10.2 Intervac (PVT) Ltd Business Overview
7.10.3 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Major Product Offerings
7.10.4 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Intervac (PVT) Ltd Key News & Latest Developments
7.11 LABIOFAM
7.11.1 LABIOFAM Company Summary
7.11.2 LABIOFAM Hemorrhagic Septicemia Vaccines Business Overview
7.11.3 LABIOFAM Hemorrhagic Septicemia Vaccines Major Product Offerings
7.11.4 LABIOFAM Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 LABIOFAM Key News & Latest Developments
7.12 Laboratorios Laverlam
7.12.1 Laboratorios Laverlam Company Summary
7.12.2 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Business Overview
7.12.3 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Major Product Offerings
7.12.4 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Laboratorios Laverlam Key News & Latest Developments
7.13 Laboratorios Ovejero
7.13.1 Laboratorios Ovejero Company Summary
7.13.2 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Business Overview
7.13.3 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Major Product Offerings
7.13.4 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Laboratorios Ovejero Key News & Latest Developments
7.14 Limor de Colombia
7.14.1 Limor de Colombia Company Summary
7.14.2 Limor de Colombia Business Overview
7.14.3 Limor de Colombia Hemorrhagic Septicemia Vaccines Major Product Offerings
7.14.4 Limor de Colombia Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 Limor de Colombia Key News & Latest Developments
7.15 National Veterinary Research Institute
7.15.1 National Veterinary Research Institute Company Summary
7.15.2 National Veterinary Research Institute Business Overview
7.15.3 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Major Product Offerings
7.15.4 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 National Veterinary Research Institute Key News & Latest Developments
7.16 Zoetis
7.16.1 Zoetis Company Summary
7.16.2 Zoetis Business Overview
7.16.3 Zoetis Hemorrhagic Septicemia Vaccines Major Product Offerings
7.16.4 Zoetis Hemorrhagic Septicemia Vaccines Sales and Revenue in Global (2018-2023)
7.16.5 Zoetis Key News & Latest Developments
8 Global Hemorrhagic Septicemia Vaccines Production Capacity, Analysis
8.1 Global Hemorrhagic Septicemia Vaccines Production Capacity, 2018-2029
8.2 Hemorrhagic Septicemia Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Hemorrhagic Septicemia Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hemorrhagic Septicemia Vaccines Supply Chain Analysis
10.1 Hemorrhagic Septicemia Vaccines Industry Value Chain
10.2 Hemorrhagic Septicemia Vaccines Upstream Market
10.3 Hemorrhagic Septicemia Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hemorrhagic Septicemia Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • アカバネワクチンのグローバル市場展望 2023年-2029年：生ワクチン、死菌ワクチン
  • ブルーアイ症候群ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、死菌ワクチン
  • 経口ポリオワクチン（OPV）のグローバル市場展望 2023年-2029年：三価OPV、二価OPV
  • 青耳豚ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、死菌ワクチン
  • インフルエンザRNAワクチンのグローバル市場展望 2023年-2029年：非複製mRNA、in vivo自己複製mRNA、in vitro樹状細胞非複製mRNAワクチン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5610 )"出血性敗血症ワクチンのグローバル市場展望 2023年-2029年：オイルアジュバントワクチン、水酸化アルミニウムアジュバントワクチン" (英文：Hemorrhagic Septicemia Vaccines Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。